Nuvectis Pharma reports mixed Phase 1b results for NXP800 in ovarian cancer, showing antitumor activity and improved safety with adjusted dosing.

What happened: The planning to move sixth grade to the middle school continues with administrators polling teachers regarding ...

By reconsidering your teaching patterns—from how you grade to where students sit—you can remind yourself of the value of ...